GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Guangzhou Wondfo Biotech Co Ltd (SZSE:300482) » Definitions » Selling, General, & Admin. Expense

Guangzhou Wondfo Biotech Co (SZSE:300482) Selling, General, & Admin. Expense : ¥746 Mil (TTM As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Guangzhou Wondfo Biotech Co Selling, General, & Admin. Expense?

Selling, general, & admin. expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. Guangzhou Wondfo Biotech Co's selling, general, & admin. expense for the three months ended in Mar. 2024 was ¥218 Mil. Its selling, general, & admin. expense for the trailing twelve months (TTM) ended in Mar. 2024 was ¥746 Mil.


Guangzhou Wondfo Biotech Co Selling, General, & Admin. Expense Historical Data

The historical data trend for Guangzhou Wondfo Biotech Co's Selling, General, & Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guangzhou Wondfo Biotech Co Selling, General, & Admin. Expense Chart

Guangzhou Wondfo Biotech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Selling, General, & Admin. Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 561.82 699.11 762.23 1,009.44 737.36

Guangzhou Wondfo Biotech Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Selling, General, & Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 210.07 158.60 248.00 120.69 218.30

Competitive Comparison of Guangzhou Wondfo Biotech Co's Selling, General, & Admin. Expense

For the Medical Devices subindustry, Guangzhou Wondfo Biotech Co's Selling, General, & Admin. Expense, along with its competitors' market caps and Selling, General, & Admin. Expense data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guangzhou Wondfo Biotech Co's Selling, General, & Admin. Expense Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Guangzhou Wondfo Biotech Co's Selling, General, & Admin. Expense distribution charts can be found below:

* The bar in red indicates where Guangzhou Wondfo Biotech Co's Selling, General, & Admin. Expense falls into.



Guangzhou Wondfo Biotech Co Selling, General, & Admin. Expense Calculation

Selling, General, & Admin. Expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. For instance, personnel cost, advertising, rent, communication costs are all part of SGA.

Selling, General, & Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥746 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Guangzhou Wondfo Biotech Co  (SZSE:300482) Selling, General, & Admin. Expense Explanation

An efficient operation keeps SGA costs low and thus has higher profit margin. The percentage of SGA relative to total revenue is an indication of how efficiently the company operates. Compare this percentage among the companies in the same industry is a good way of finding more efficient operations. A comparison of the SGA cost relative to the revenue with the historical value can also be an indication of how efficient the company has become.

Warren Buffett likes companies with consistent SGA as the percentage of gross profit.

Companies with no durable competitive advantage show wild variation in SG&A as % of Gross Profit.

If SGA is less than 30% of Gross Profit, it is fantastic. If SGA is nearing 100%, it is is in highly competitive industry.


Guangzhou Wondfo Biotech Co Selling, General, & Admin. Expense Related Terms

Thank you for viewing the detailed overview of Guangzhou Wondfo Biotech Co's Selling, General, & Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Guangzhou Wondfo Biotech Co (SZSE:300482) Business Description

Traded in Other Exchanges
N/A
Address
No. 8, Lizhishan Road, Science City, Luogang District, Guangdong, Guangzhou, CHN, 510641
Guangzhou Wondfo Biotech Co Ltd manufactures medical diagnostic tests. Its products include immunodiagnostic rapid test kits, including fertility, which include pregnancy HCG, ovulation LH, and others. The company's products are used in a clinical test, field test, and personal health management, among others.
Executives
He Xiao Wei Director
Kang Ke Ren Executives
Yu Fang Xia Executives
Li Wen Mei Directors, executives
Wang Ji Hua Director
Peng Zhong Xiong Executives
Zhao Ya Ping Executives
Luo Hong Supervisors
Zhou Yong Supervisors

Guangzhou Wondfo Biotech Co (SZSE:300482) Headlines

No Headlines